Accessed January 3, 2023
Researchers are investigating semaglutides potential effectiveness in treating alcohol use disorder (AUD) by reducing alcohol consumption and related harmful behaviors, such as heavy drinking and binge drinking
As observed in the STEP trials, treatment discontinuations due to AEs occurred in 2.4%7.0% of participants receiving semaglutide, compared with 1.0%4.6% of those receiving placebo [13, 38,39,40,41,42,43,44,45,46]
However, in addition to the frequent headlines about the health benefits of semaglutide, there have also been concerns raised about potential negative side-effects, with suggestions of an increased risk of pancreatitis and loss of bone, vision and muscle
Without that antimicrobial agent, bacteria can colonize the solution after the first needle puncture